A randomized trial of a theory-driven model of health coaching for older adults: short-term and sustained outcomes

Abstract

Background: Healthy Lifetime, a theoretically driven, personalized health coaching program delivered electronically, including face-to-face videoconferencing, was developed to intervene in early aging to stave off functional decline and minimize the onset/exacerbation of chronic conditions. Objective: To determine the efficacy of a theoretically driven, personalized health coaching program in participants 50 years and older with one or more chronic conditions using a randomized, controlled, pragmatic clinical trial methodology. Methods: Participants were randomly assigned to the HL (n = 59) or a usual care (n = 63) group. The HL group received health coaching from a trained nurse over eight weeks. Outcomes were measured at baseline, eight weeks, and 20 weeks (after the 12-week no-treatment phase). Regression modeling with fixed-effect repeated measures was used to account for the longitudinal data collection. Results: For the HL group, health habits increased at 8 weeks (3.1 units; SE = 1.0; p =.0005; effect size =.15). This difference was sustained at 20 weeks (2.4 units, SE = 0.2; p =.0005). Independent self-care agency improved at 8 weeks in individuals with high blood pressure (13.5 units; SE = 4.37; p =.0023; effect size =.3). However, that difference was not sustained at 20 weeks (p =.47). No significant improvements were shown in the usual care group at 8 weeks or 20 weeks. Conclusions: HL participants significantly improved their health habits at 8 weeks and sustained this improvement at week 20 (after a 12-week no-treatment phase) vs. the usual care group. Changing health habits alone has been shown to reduce all-cause morbidity and mortality in chronic disease. The high-functioning, community-dwelling older adults with chronic diseases we studied is an important target population for primary care practices to intervene early in aging to stave off the complications of chronic disease and functional decline. Trial registration: ClinicalTrials.gov (record NCT05070923, 07/10/2021).